By Mollie Shields-Uehling, President & CEO,
as posted on Pharma iQ 08/19/2014
Mollie Shields-Uehling, President & CEO,
There is elegance in the apparently simple solution to the complex problem.
I say “apparently” because so many solutions are complicated in their detail and the people responsible for them struggle to tell their stories in simple terms — in ways that decision-makers and end-users can understand and appreciate.
That’s why we at SAFE-BioPharma have been on a quest to make the standard easier to understand for those concerned with improving digital workflows, systems, and business processes, in general.
The standard addresses many technical and regulatory details. We’re always available to lift the hood and take those who are interested or need to know on a thorough and detailed tour of how the SAFE-BioPharma standard for managing digital identities and applying digital signatures operates.
But how to get the message to a point where it can be understood by the many?
We recently decided to focus our message around benefits and the Number 1.
• First, readers should know that SAFE-BioPharma is the one industry collaboration helping to improve productivity, reduce costs, and lower time to market by protecting information assets, moving business processes online, and becoming paperless.
• SAFE-BioPharma also is the only identity standard created by the biopharmaceutical industry and its regulators to provide high-assurance identity trust for cyber-transactions across the biopharmaceutical and healthcare sectors. Identity credentials compliant with the standard are regulatory complaint and will be trusted by all US Government agencies, other companies in the SAFE-BioPharma systems and with companies in other industries with similar systems.
• Identity credentials based on the SAFE-BioPharma standard are like a single, trusted, interoperable Internet passport used to authenticate and manage identity and to apply secure digital signatures in electronic transactions. Signatures are linked to the individual’s identity. They are legally enforceable and non-repudiable. They ensure an eDocument’s integrity for as long as the document exists.
• They also are part of one global ecosystem, a rapidly expanding network of users, credential issuers, applications, services and solutions governed by the SAFE-BioPharma Standard. This means that all compliant products can be confidently used by industry with the knowledge they are acceptable to industry and regulators in the United States, Europe and around the globe.
For a more thorough look at how we’re explaining what we do and why we do it, please visit our new homepage at www.safe-biopharma.org.
I hope you see the value of the Standard’s benefits and agree with our use of the power of One.